**Abstract**

Human chromosome 15q25.2--25.3 deletion syndrome has recently been reported as one of the copy number variations associated with intellectual delay (ID) and mental retardation (MR) (Cooper et al., Nat. Genet., 2011). Patients with 15q25.2--25.3 (660 Kb, include 7 genes, ZSCAN2, WDR73, NMB, ZNF592, ALPK3, SLC28A1, and PDE8A) microdeletion manifest variable clinical features, including mild motor delay, myopathy, mild cognitive deficits, and ASD (autism spectrum disorders)-like symptoms. So far causal factors and mechanical evidences relevant to neuropsychiatric phenotypes have not been addressed. To analyze the consequence of 15q25.2--25.3 deletion, we developed animal model of human 15q25.2--25.3 heterozygous haploinsufficiency by chromosome engineering. Although this mutant mouse harboring 0.5 Mb deletions in chromosome 7 that corresponds to human 15q25.2--25.3 appeared normal and displayed no gross abnormalities so far, sequential behavioral analyses identified anxiety phenotypes in both open-field and elevated-plus maze tests. This mutant mouse also showed behavioral inflexibility in reversal learning test of Barnes maze although its hippocampal dependent spatial learning and memory tasks are normal. We report our progress of phenotypic analysis and discuss about its future perspectives.
